IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study

NCT05417269 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: IMCY-0141
DRUG: Placebo
DRUG: Dimethyl Fumarate

Sponsor

Imcyse SA